PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People\'s Republic of China.\', \'Jiangsu Recbio Technology Co., Ltd., Taizhou, China.\', \'Acro Biosystems, Inc., Beijing, People\'s Republic of China.\', \'CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People\'s Republic of China.\', \'Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, People\'s Republic of China.\', \'National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2022.2054369
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 35293847
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35293847>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35293847>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all